Episode 191: Doravirine & Islatravir Update episode artwork

EPISODE · May 28, 2026 · 19 MIN

Episode 191: Doravirine & Islatravir Update

from NECA in the Know · host NECA AETC

This week, Marianna sits down with John Faragon to talk about the recent approval of doravirine and islatravir and the FDA label. Tune in to learn all about indication, dosage, administration, and more. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=EPP8742)--Want to chat? Email us at [email protected] with comments or ideas for new episodes. --Check out our free online courses: https://www.necaaetc.org/self-paced-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691 

Episode metadata supplied by the publisher feed · Published May 28, 2026

Embed this episode

NOW PLAYING

Episode 191: Doravirine & Islatravir Update

0:00 19:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of NECA in the Know?

This episode is 19 minutes long.

When was this NECA in the Know episode published?

This episode was published on May 28, 2026.

Can I download this NECA in the Know episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!